**About the Editor**

**Fadi Aldeek**, Ph.D., serves as a Principal Scientist, Analytical Sciences, at Altria Client Services (ALCS) in Richmond, VA. In this role, he leads multiple analytical sciences research and development projects to expand analytical testing capabilities for novel oral nicotine-containing products and provides scientific insights to aid the development of reduced-risk products. Dr. Aldeek also provides technical oversights for other scientists and supports Altria's external engagement strategy. Dr. Aldeek's current research focuses on the development and validation of analytical methods to improve the analysis of constituents in reduced-risk products for regulatory reporting and for the support of product development. His research addresses all aspects of the analytical process, including sample preparation, extraction, separations, dissolution testing, detection, screening, quantification, identification, and data processing using a variety of state-of-the-art analytical technologies. Before joining the Altria family of companies in 2018, Dr. Aldeek was a Senior Scientist Group Leader at Eurofins Lancaster Laboratories (Richmond, Va.), leading an analytical chemistry team. Prior to this position, he served as a Senior Scientist at the Florida Department of Agriculture and Consumer Services where he established the Drug Residues Program to screen for antibiotics in various food matrices. Dr. Aldeek has also held positions at several academic institutions as a Research Fellow and Adjunct Professor. Dr. Aldeek is a co-author of more than 40 scientific peer-reviewed publications and 2 book chapters in his area of expertise. He is also co-author of over 60 presentations given at various national and international scientific meetings. Dr. Aldeek serves as associate and guest editor for the Journal of Nanomedicine Research, the Nanomaterials and Nanotechnology Journal, the Science Journal of Analytical Chemistry, and Separations.
